Generic painkiller put to the test against Brand-Name drug in breast surgery patients
NCT ID NCT07154446
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 27 times
Summary
This study aims to see if a generic version of a painkiller (Parestat) works as well as the original brand (Dynastat) for pain after breast surgery. About 60 adults having breast biopsies will be randomly assigned to receive one of the two drugs. Their pain levels and any side effects like nausea or blood pressure changes will be tracked for 24 hours after surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST EXICISION BIOPSY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.